WBC RULING REGARDING BERMANE STIVERNE’S
WBC CPB ADVERSE FINDING
ISSUED BY WBC BOARD OF GOVERNORS
November 14, 2016
I. ADVERSE FINDING
On November 11, 2016 VADA notified the WBC that Bermane Stiverne’s anti-doping test taken from his November 4, 2016 sample (the “Test”) pursuant to the WBC Clean Boxing Program (“CPB”) yielded an adverse finding for the banned substance methylhexaneamine (also known as dimethyamylamine or “DMAA”).